Waters | Wyatt Technology’s Post

The compelling investment argument for Stevenage starts with the dominance of our Cell & Gene therapy development. Our next chapter in STEM product delivery is starting soon in Space & Communications. Stevenage is fast becoming STEMenage

Cell and gene therapy in the Asia-Pacific region https://lnkd.in/efNFUyFj learnings from local case studies. In this update, we share two case studies that explore how local innovators in the cell and gene therapy space in Asia-Pacific are addressing some of the major challenges for access in the region: that of overcoming complex manufacturing and delivery and improving affordability. https://lnkd.in/efNFUyFj #MarketAccess #HEOR #WeAreAvalereHealth

Discover the future of cell and gene therapy with Caidya at CAR-TCR. Come and have a chat with Adam Marsh and I. #CARTCRsummit #genetherapy #celltherapy #Caidya

Cell and gene therapy developers, want to learn more about off-target effects during #geneediting, or our novel approach to overcome this challenge to develop therapies that are safer by design? Reserve your free spot in our upcoming webinar with Felix Dobbs: bit.ly/brokenstringwebinar #CRISPR

With the new era of cell and gene therapy upon us, the major challenge is how to successfully and effectively commercialize your products. Experts in CGT shared insights here: https://bit.ly/3vfg3mf #cgttherapy #celltherapy #genetherapy

We explore phenotyping of non-epileptic phenomena, discovery of sodium channels for gene therapy, and drug research in the pipeline 🧬 #Epilepsy #MedicalAdvancements

Poster presentation at Healthcare Next 2K24, International Conference focused on "Transformations in Healthcare Research: Prospects, Challenges and Sustenance, GITAM Deemed University about "Nanocarriers: A Novel Strategy for Cell and Gene Therapy"

As we approach #RareDiseaseDay, our Development Head of Cell and Gene Therapy, Carolyn Sasse recently published an article on the importance of #patient voice in advancing therapies for #rarediseases. Read the full piece here: https://lnkd.in/gARR94JP

Overcome challenges like tedious revalidation and costly optimization during cell and gene therapy scale-up. With scalable technologies and flexible formats, we help you avoid problems with yield and process consistency, so you can meet increasing patient demand efficiently: https://sar.to/73hd8 #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy

Want to learn about how the #AdvancedTherapies industry in the UK has progressed in the last few years? Read the Cell and Gene Therapy Catapult Annual Review 2023 to learn more about the growth of the industry and where it is heading: https://lnkd.in/euU5Fuii #CellTherapy #GeneTherapy #ATMPs